Kusurinomadoguchi (5592) investor relations material

Executive summary

• Achieved record consolidated revenue and operating profit for the third quarter, driven by strong performance in the Media and Minna no Okusuri Bako businesses, with stock-type gross profit also reaching new highs year-over-year.

• Revenue for the nine months ended December 31, 2025, increased 6.0% year-over-year to ¥8,927 million, driven by stable growth in the media business and new customer acquisition in the pharmacy support segment.

• Operating profit rose 29.5% year-over-year to ¥2,015 million, and net profit attributable to shareholders surged 35.2% to ¥2,112 million, aided by cost optimization and deferred tax assets from a prior subsidiary merger.

• Cost optimization, especially in subsidiaries, contributed to improved operating margins and reduced SG&A expenses compared to the previous year.

• The company completed the acquisition of Medi-Web via a share exchange effective January 1, 2026, expanding its reach into the medical institution portal market.

Financial highlights

• Consolidated revenue for Q3 YTD was ¥89.2 billion, up 6% year-over-year.

• Operating profit rose 24% year-over-year to ¥754 million; EBITDA increased 20% to ¥1,127 million.

• Net income attributable to parent company shareholders decreased 51% year-over-year due to prior-year tax adjustments.

• Gross profit for the period was ¥5,084 million, up from ¥5,002 million in the prior year.

• Total assets at period-end were ¥14,887 million, up from ¥12,157 million at the previous fiscal year-end.

Outlook and guidance

• Full-year revenue forecast revised to ¥12.3 billion, up 9.8% from the previous year.

• Operating profit guidance raised to ¥2.45 billion (+25.4% YoY); net income forecast at ¥2.69 billion (+32.2% YoY).

• Annual dividend increased from ¥30 to ¥36 per share.

• Newly consolidated subsidiaries' results not yet reflected in guidance.